Hypertension Diagnostics Correlations

HDIIDelisted Stock  USD 0  0.0008  38.10%   
The current 90-days correlation between Hypertension Diagnostics and LiveChain is -0.03 (i.e., Good diversification). The correlation of Hypertension Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Hypertension Diagnostics Correlation With Market

Significant diversification

The correlation between Hypertension Diagnostics and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Hypertension Diagnostics and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Hypertension Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hypertension Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hypertension Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hypertension Diagnostics to buy it.

Moving against Hypertension Pink Sheet

  0.45VIVE Viveve MedicalPairCorr
  0.43BIO Bio Rad LaboratoriesPairCorr
  0.41ESTA Establishment LabsPairCorr
  0.37MDT Medtronic PLCPairCorr
  0.33VTAK Catheter PrecisionPairCorr
  0.33BVS BioventusPairCorr
  0.38TLSIW TriSalus Life SciencesPairCorr
  0.32VMD Viemed HealthcarePairCorr
  0.31ICAD icad incPairCorr
  0.31ICCM Icecure MedicalPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
APHDPMPG
USCSPMPG
USCSAPHD
SMEVCLHI
SMEVJADA
JADACCAJ
  
High negative correlations   
SVADCCAJ
SVADJADA
SVADSMEV
SVADCLHI
TMXNLICH
TMXNCCAJ

Risk-Adjusted Indicators

There is a big difference between Hypertension Pink Sheet performing well and Hypertension Diagnostics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Hypertension Diagnostics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
LICH  30.94  12.30  0.22 (1.81) 17.86 
 204.17 
 420.71 
CLHI  9.03  0.81  0.02 (1.26) 12.12 
 44.12 
 129.92 
PMPG  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CCAJ  17.45  3.13  0.10 (0.82) 16.48 
 42.86 
 164.44 
JADA  11.35  2.20  0.08 (23.40) 11.91 
 51.61 
 134.17 
SMEV  4.94  0.21 (0.01)(0.02) 6.27 
 19.44 
 52.73 
APHD  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
USCS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
TMXN  13.22  2.70  0.08 (1.67) 13.64 
 50.00 
 154.55 
SVAD  4.43  1.67  0.00 (0.31) 0.00 
 0.00 
 83.33 

Hypertension Diagnostics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hypertension Diagnostics pink sheet to make a market-neutral strategy. Peer analysis of Hypertension Diagnostics could also be used in its relative valuation, which is a method of valuing Hypertension Diagnostics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Still Interested in Hypertension Diagnostics?

Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.